Recombinant DNA expression vectors
US5658759A · kind A · utility
21Cited by
1References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 16, 1996 |
| Grant date | Aug 19, 1997 |
| Priority date | — |
| Expiry date | Apr 16, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/42
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides expression vectors containing the promoter, enhancer and substantially complete 5'-untranslated region including the first intron of the major immediate early gene of human cytomegalovirus. Further vectors including the hCMV-MIE DNA linked directly to the coding sequence of a heterologous gene are described. Host cells transfected with the vectors and a process for producing heterologous polypeptides using the vectors and the use of the hCMV-MIE DNA for expression of a heterologous gene are also included within the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.